Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91
Published October 22, 2025 · Recall initiated: September 5, 2025
Summary
FDA records drug Class III recall D-0026-2026, published October 22, 2025 and initiated September 5, 2025. Recalling firm: Endo USA, Inc.; Status: Ongoing; Reported quantity: 1,041 cartons; Lot: Lot #: 550172301, Exp. Date January 2026. Class III means the product is not likely to cause adverse health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Endo USA, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: 550172301, Exp. Date January 2026
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAEverolimus tablets 7.5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,November 5, 2025
- FDAEverolimus tablets 2.5 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,November 5, 2025
- FDAEverolimus tablets 10 mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,November 5, 2025
- FDAEverolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only,November 5, 2025
- FDAFentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc.,October 22, 2025
- FDASucralfate Tablets, USP 1 gram, 100 Tablets, (10x10), Rx Only, Distributed by: American Health Packaging,October 22, 2025
Questions about this recall
Was Everolimus tablets 5mg, 28 tablets (each carton contains 4 blister strips with 7 tablets each), Rx only, Manufactured by: Par Pharmaceutical Chestnut Ridge, NY 10977, NDC 49884-125-91 recalled?
Yes. FDA published recall D-0026-2026 on October 22, 2025. Reported hazard: Failed Impurities/Degradation Specifications: Out of specification for impurity IP-C.
What should I do if I have this product?
Voluntary: Firm initiated · Letter